H3-DYNAMICS
23.11.2022 07:01:43 CET | Business Wire | Press release
The future of hydrogen aviation powered by H3 Dynamics’ distributed hydrogen propulsion nacelles has taken flight for the very first time in France.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121006001/en/
H3 Dynamics distributed hydrogen electric nacelles proven on first flight (Photo: Business Wire)
Following the announcement of its hydrogen aviation concept back in 2018, H3 Dynamics managed to become a topic at an Oval Office press conference on the very next day, and started what is now a global hydrogen aviation movement.
In November 2021, H3 Dynamics completed its first working hydrogen propulsion nacelle prototype. In July 2022, the first distributed pod system took to the skies on a scaled-down aircraft at “Hub Drones - Systematic” airfield near Paris. The hydrogen flight received clearance from the French civil air authorities (DGAC).
H3 Dynamics’ self-contained nacelle approach addresses technical, safety and cost challenges hydrogen aircraft developers could face at some point in the future. It achieves this by placing hydrogen and smaller fuel cells across a series of collaborative propulsion nacelles under the wings. A new 2022 study forecasts the global thrust nacelle market to reach $7 Billion by 2030 highlights H3 Dynamics’ hydrogen solution as a key new opportunity in the sector.
Other, higher-visibility hydrogen aircraft proponents will fly larger size aircraft much sooner – but they will do so by converting existing aircraft using fuel cells sourced from the automotive world – and storing large amounts of gas or liquid hydrogen inside the main fuselage.
“Not only is safety our first priority, but we don’t want hydrogen competing for revenue-generating airfreight and passenger space,” said Taras Wankewycz, Founder/CEO of H3 Dynamics. Distributing small systems solves technical headaches, such as thermal management, and increases safety through multiple redundancy.
H3 Dynamics’ 25kg test aircraft is already a breakthrough - with an electric flight range of up to 900km on liquid hydrogen, or 350km with pressurized hydrogen. Its externalized nacelle design also frees up 30L of fuselage volume with no hydrogen nor any powertrain elements inside. H3 Dynamics’ hydrogen propulsion nacelles could potentially become a “snap-on” retrofit for battery-powered unmanned eVTOL or fixed wing cargo drones.
Preparing for the arrival of much longer duration unmanned hydrogen flights - H3 Dynamics started to work on airspace safety with world-leading air traffic control companies. It has been building experience with high-volume enterprise data services being deployed in smart cities such as Singapore, and gradually coupling these with drone-agnostic charging stations.
By starting at the lower-end boundary of regulatory and certification efforts, H3 Dynamics doesn’t need to wait until 2035 to begin its commercial journey. “We all need to learn today with small commercial applications and gradually increase aircraft size over time together with all stakeholders – most importantly, the regulators.”
Now H3 Dynamics is already preparing its next steps.
It is exploring liquid hydrogen integration as part of a joint-development with ISAE-SUPAERO in Toulouse launched in 2019. The objective is a historical and symbolic Atlantic crossing on hydrogen electric propulsion in the coming two years.
And with airfield experiments feeding its digital twin capability for hydrogen aircraft design, H3 Dynamics is now working on a next generation platform powered by 6 independent hydrogen-electric nacelle systems. The aircraft will feature fast-refueling and will be used as a test bed for H3 Dynamics hydrogen-electric propulsion technology moving forward.
About H3 Dynamics: www.h3dynamics.com
H3 Dynamics is on a long-term mission to decarbonize aviation with a unique technology solution around distributed hydrogen-electric propulsion, as well as ground refueling solutions. While the commercial opportunities around passenger-scale hydrogen aviation continue to mature, the company is implementing an incremental product and services roadmap that solves safety, technical, regulatory challenges starting small and simple, adding scale and complexity over time. The company currently has 95 employees and serves clients globally from its 3 regional headquarters in Toulouse, Austin and Singapore. H3 Dynamics is member of the Alliance for Zero Emission Aviation under the European Commission, the Lufthansa Cleantech Hub, Paris Advanced Air Mobility Alliance, and Aerospace Valley in Toulouse.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221121006001/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Xsolla Brings Mobile-First Monetization Expertise to Gamesforum Barcelona 2026, Where Europe's Mobile Gaming Leaders Gather to Solve the Industry's Toughest Growth Challenges9.2.2026 20:30:00 CET | Press release
Platform That Powers 1,500+ Game Developers Across 200+ Geographies Expands Commerce, Payment, and Distribution Infrastructure to Adjacent Creative Industries Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced its participation in Gamesforum Barcelona 2026, taking place Feb.10-11 at the InterContinental Hotel in Barcelona. This event brings together Europe's sharpest minds in mobile gaming for practical, data-driven sessions focused on what actually works in today's hypercompetitive mobile landscape. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209301026/en/ (Graphic: Xsolla) With over 600 professionals from Europe's top publishers, ad networks, and studios in attendance, Gamesforum Barcelona has earned its reputation as the place where mobile gaming's most pressing problems get solved: How do you scale profitably? How do you retain players in satur
Beast Industries Acquires Step, Expanding its Platform to Include Financial Services9.2.2026 18:30:00 CET | Press release
This strategic acquisition brings innovative fintech capabilities to Beast Industries’ growing global platform, combining technology, content, and purpose to redefine financial services for the next generation Beast Industries, the largest and most innovative creator based platform in the world, today announced the acquisition of Step, a financial technology company dedicated to making financial literacy and money management accessible to all. This acquisition marks a significant milestone for Beast Industries, bringing together Step's robust technology platform and full-stack fintech team with Beast Industries’ extensive audience reach and proven track record in philanthropic initiatives. Together, the combined organization will deliver innovative solutions that make financial wellness achievable for people at every step of their life journey. "Financial health is fundamental to overall wellbeing, yet too many people lack access to the tools and knowledge they need to build financial
Align Partners Issues Public Shareholder Letter and Submits Formal Shareholder Proposals to DB Insurance9.2.2026 15:26:00 CET | Press release
Align Partners underscores DBI’s persistent undervaluation (0.40x Adjusted PBR), despite industry-leading profitability, identifying inefficient capital allocation and governance issues as primary driversAlign Partners outlines measures for capital efficiency and governance normalization; requests a revised “Value-up” plan and a formal response from the Board by March 6, 2026The proposals nominate two Independent Directors via separate election and calls for the reinstatement of the Internal Transaction Committee Align Partners Capital Management Inc. (“Align Partners”), a shareholder of DB Insurance Co., Ltd. (KRX:005830) (“DBI” or the “Company”) holding 1.9%, has issued a public shareholder letter to DBI’s Board of Directors aimed at strengthening capital allocation policy and governance oversight, and submitted formal shareholder proposals for the 2026 Annual General Meeting (“AGM”). Despite DBI’s robust fundamentals—including a 16.1% ROE and a 226% K-ICS ratio—the Company trades at
Promega Unveils Cellular Target Engagement Technology Aimed at Expanding the Druggable Proteome at SLAS 20269.2.2026 13:00:00 CET | Press release
TarSeer™ BRETSA™ Target Engagement System enables studies for difficult proteins early in drug discovery Promega Corporation is launching a new live-cell target engagement platform that could close a long-standing gap between biochemical and cellular assays for understudied or difficult-to-interrogate proteins. The TarSeer™ BRETSA™ Target Engagement System is a novel bioluminescence resonance energy transfer-based shift assay for detecting ligand-protein interactions in intact cells using protein denaturation. It gives drug discovery researchers early, target-specific cellular insights by validating weak or early chemical matter and expanding the targets accessible in live-cell drug discovery workflows. The technology will be debuted at the Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in Boston, February 7-11, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260206015371/
Eurofins Viracor BioPharma Expands Bioanalytical Capabilities9.2.2026 13:00:00 CET | Press release
Eurofins Viracor BioPharma Services, a long‑standing and trusted partner for clinical trial testing solutions with deep expertise in specialty biomarkers and molecular assays, announces a significant expansion of its service portfolio with the addition of enhanced bioanalytical testing capabilities. These new services are fully aligned with Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), enabling the company to enhance support of biopharmaceutical development programs with greater scientific breadth throughout the drug development workflow. This strategic advancement follows the successful relocation and integration of Eurofins Pharma Bioanalytics Services from St. Charles, Missouri, into Eurofins Viracor BioPharma’s purpose‑built, eleven‑acre facility in Lenexa, Kansas. The bioanalytical organization brings more than two decades of specialized experience in pharmacokinetics, immunogenicity, and biomarker testing. By combining both laboratories’ strengths, Eurofins V
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
